乳头脏细胞癌:当前的证据和未来的方向
Albert Jang1, Charbel S Hobeika2, Shilpa Gupta3
1Section of Solid Tumor Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA.
Kidney cancer (Clifton, Va.)
|March 3, 2025
概括
与清晰细胞RCC (ccRCC) 相比,乳头细胞癌 (pRCC) 在转移阶段的结果较差. 需要更多专门的临床试验来改善pRCC治疗和结果.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生殖尿道癌症 生殖尿道癌症
背景情况:
- 乳头性细胞癌 (pRCC) 占细胞癌 (RCC) 病例的15-20%.
- 虽然局部的PRCC显示出更好的结果,但转移性PRCC的预后明显比转移性透明细胞RCC (ccRCC) 更糟糕.
- 对pRCC的有限研究和临床试验需要从ccRCC疗法进行治疗外推.
研究的目的:
- 审查pRCC.的病理生理学和遗传特征.
- 概述从细胞因子时代到当前方法的pRCC治疗策略的演变.
- 突出目前管理pRCC的挑战和专门进行临床试验的需要.
主要方法:
- 关于PRCC病理生理学,遗传学和治疗演变的文献综述.
- 分析当前的治疗策略,包括氨酸激酶抑制剂和免疫检查点抑制剂.
- 讨论pRCC管理中的结果和挑战.
主要成果:
- pRCC表现出与ccRCC不同的特征,特别是在转移性环境中.
- 新兴的治疗方法,如氨酸激酶抑制剂显示出希望,特别是与免疫检查点抑制剂结合使用.
- 目前的治疗响应率和pRCC的结果仍然落后于ccRCC.
结论:
- 迫切需要针对pRCC进行专门的临床试验.
- 优化PRCC管理需要对其独特特征有更深入的了解.
- 针对性疗法和免疫疗法的进展有可能改善PRCC患者的治疗结果.
更多相关视频
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.5K
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
8.8K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K